Recently, the American College of Cardiology and the American Heart Association called for the inclusion of cost-effectiveness assessments and recommendations in practice guidelines.7 The main objective of this study was to estimate the incremental health gains and cost-effectiveness of implementing the strongest recommendations for hypertension therapy (i.e., those based on the results of clinical trials) in the 2014 guidelines among U.S. adults.